Trusted News Discovery Since 2008
{{/content}}
Bharat Biotech will involve 3,000 people for phase-III trials of COVID vaccine in UP
Video Credit: ANI
Published on September 30, 2020 - Duration: 01:36s
Bharat Biotech will involve 3,000 people for phase-III trials of COVID vaccine in UP
Speaking on phase-III trials of the COVID-19 vaccine, Uttar Pradesh Health Minister Jai Pratap Singh on September 29 said Bharat Biotech will involve 3,000 people from the state- 1,500 each from Lucknow and Gorakhpur.
He said, "Phase-III trials of the COVID-19 vaccine being developed by Bharat Biotech will involve 3,000 people- 1,500 each from Lucknow and Gorakhpur."
You are here
Related news from verified sources
Vaccine major Bharat Biotech has joined hands with inked a licensing agreement with the Washington University School of Medicine in St. Louis for developing,...
on September 23, 2020 • IndiaTimes
The first phase of the clinical trials for Bharat Biotech's coronavirus disease (COVID-19) vaccine being developed at Post Graduate Institute (PGI) Rohtak has...
on September 8, 2020 • DNA
In a good news for millions of Indians, the coronavirus COVID-19 vaccine ‘Covaxin’ will be tested for its phase-3 trials in Uttar Pradesh’s Lucknow and...
on September 24, 2020 • Zee News
Related videos from verified sources
New promising results from Moderna vaccine trial 00:21
Video credit: KTNV Channel 13 Las Vegas - Published on September 30, 2020
Covid vaccine: Covaxin phase 3 trials on 3,000 people in UP, says minister 02:29
Video credit: HT Digital Content - Published on September 30, 2020
Moderna and Regeneron Jump on Positive Covid-19 Vaccine Trials 02:37
Video credit: The Street - Published on September 30, 2020